EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome

Md Belal Hossain iD, Hubert Wong, Mohsen Sadatsafavi, Victoria J Cook, James C Johnston, Mohammad Ehsanul Karim iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Md Belal Hossain und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Health administrative databases often contain no information on some important confounders, leading to residual confounding in the effect estimate. We aimed to explore the performance of high‐dimensional disease risk score (hdDRS) to deal with residual confounding bias for estimating causal effects with survival outcomes.

Methods

We used health administrative data of 49 197 individuals in British Columbia to examine the relationship between tuberculosis infection and time‐to‐development of cardiovascular disease (CVD). We designed a plasmode simulation exploring the performance of eight hdDRS methods that varied by different approaches to fit the risk score model and also examined results from high‐dimensional propensity score (hdPS) and traditional regression adjustment. The log‐hazard ratio (log‐HR) was the target parameter with a true value of log(3).

Results

In the presence of strong unmeasured confounding, the bias observed was −0.11 for the traditional method and −0.047 for the hdPS method. The bias ranged from −0.051 to −0.058 for hdDRS methods when risk score models were fitted to the full cohort and −0.045 to −0.049 when risk score models were fitted only to unexposed individuals. All methods showed comparable standard errors and nominal bias‐eliminated coverage probabilities. With weak unmeasured confounding, hdDRS and hdPS produced approximately unbiased estimates. Our data analysis, after addressing residual confounding, revealed an 8%–11% higher CVD risk associated with tuberculosis infection.

Conclusions

Our findings support the use of selected hdDRS methods to address residual confounding bias when estimating treatment effects with survival outcomes. In particular, the hdDRS method using rate‐based risk score modeling on unexposed individuals consistently exhibited the least bias. However, the hdPS method showed comparable performance across most evaluated scenarios. We share reproducible R codes to facilitate researchers' adoption and further evaluation of these methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesTuberculosisHumansBiasConfounding Factors, EpidemiologicFemaleMaleBritish ColumbiaMiddle AgedPropensity ScoreDatabases, FactualProportional Hazards ModelsAdultTreatment OutcomeAgedCohort StudiesRisk FactorsRisk AssessmentComputer Simulation

Stichwörter der Autor:innen

health administrative datahigh‐dimensional disease risk scorehigh‐dimensional propensity scoreresidual confoundingsurvival outcome

Autor:innen und Institutionen

  • School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Centre for Advancing Health Outcomes, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Md Belal Hossain, Mohammad Ehsanul Karim

Zitieren

APA

Hossain, M. B., Wong, H., Sadatsafavi, M., Cook, V. J., Johnston, J. C., & Karim, M. E. (2025). High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70172

Vancouver

Hossain MB, Wong H, Sadatsafavi M, Cook VJ, Johnston JC, Karim ME. High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70172

BibTeX
@article{Hossain2025,
  author = {Hossain, Md Belal and Wong, Hubert and Sadatsafavi, Mohsen and Cook, Victoria J and Johnston, James C and Karim, Mohammad Ehsanul},
  title = {High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70172}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche